Mid-Florida Hematology and Oncology Center — Orange, Florida

Mid-Florida Hematology and Oncology Center is a clinical research site located in Orange, Florida, United States 32763.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-Florida Hematology and Oncology Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: NSCLC.

Sponsors: Eikon Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orange

Browse all research sites in Florida · View every site in Orange

• Children's Hospital of Orange County (CHOC Children's)
• University of California Irvine
• Mid Florida Hematology Oncology
• Mid Florida Hematology And Onc Ctr
• Optimal Research Sites
• Hs0001 111
• Novartis Investigative Site
• Actavis Investigational Study Site #151
• Progressive Medical Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Florida Hematology and Oncology Center?

Mid-Florida Hematology and Oncology Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Florida Hematology and Oncology Center conducted?

Mid-Florida Hematology and Oncology Center has 1 clinical trials on record, with 1 currently active. Their work covers NSCLC.

Is Mid-Florida Hematology and Oncology Center accredited by Crixeo Clinical Trials?

Mid-Florida Hematology and Oncology Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Florida Hematology and Oncology Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.